These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19264782)

  • 1. c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.
    Faumont N; Durand-Panteix S; Schlee M; Grömminger S; Schuhmacher M; Hölzel M; Laux G; Mailhammer R; Rosenwald A; Staudt LM; Bornkamm GW; Feuillard J
    J Virol; 2009 May; 83(10):5014-27. PubMed ID: 19264782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
    Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
    Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes.
    Wang C; Li D; Zhang L; Jiang S; Liang J; Narita Y; Hou I; Zhong Q; Zheng Z; Xiao H; Gewurz BE; Teng M; Zhao B
    J Virol; 2019 Jul; 93(13):. PubMed ID: 31019051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice.
    Bristol JA; Nelson SE; Ohashi M; Casco A; Hayes M; Ranheim EA; Pawelski AS; Singh DR; Hodson DJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2024 Apr; 20(4):e1012132. PubMed ID: 38620028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of c-myc in lymphoblastoid cells does not support an Epstein-Barr virus latency III-to-I switch.
    Pajic A; Polack A; Staege MS; Spitkovsky D; Baier B; Bornkamm GW; Laux G
    J Gen Virol; 2001 Dec; 82(Pt 12):3051-3055. PubMed ID: 11714983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
    Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
    J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
    Price AM; Messinger JE; Luftig MA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.
    Zhao B; Zou J; Wang H; Johannsen E; Peng CW; Quackenbush J; Mar JC; Morton CC; Freedman ML; Blacklow SC; Aster JC; Bernstein BE; Kieff E
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14902-7. PubMed ID: 21746931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.
    Pajic A; Staege MS; Dudziak D; Schuhmacher M; Spitkovsky D; Eissner G; Brielmeier M; Polack A; Bornkamm GW
    Int J Cancer; 2001 Sep; 93(6):810-6. PubMed ID: 11519042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.
    David A; Arnaud N; Fradet M; Lascaux H; Ouk-Martin C; Gachard N; Zimber-Strobl U; Feuillard J; Faumont N
    Haematologica; 2017 May; 102(5):883-894. PubMed ID: 28232371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
    Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
    J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.
    Gordadze AV; Peng R; Tan J; Liu G; Sutton R; Kempkes B; Bornkamm GW; Ling PD
    J Virol; 2001 Jul; 75(13):5899-912. PubMed ID: 11390591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE; Ward K; Rickinson AB; Rowe M
    Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Kelly G; Bell A; Rickinson A
    Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
    Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
    PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBNA2-deleted Epstein-Barr virus (EBV) isolate, P3HR1, causes Hodgkin-like lymphomas and diffuse large B cell lymphomas with type II and Wp-restricted latency types in humanized mice.
    Li C; Romero-Masters JC; Huebner S; Ohashi M; Hayes M; Bristol JA; Nelson SE; Eichelberg MR; Van Sciver N; Ranheim EA; Scott RS; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Jun; 16(6):e1008590. PubMed ID: 32542010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
    Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
    PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Epstein-Barr virus-regulated host gene expression changes through primary B-cell outgrowth reveals delayed kinetics of latent membrane protein 1-mediated NF-κB activation.
    Price AM; Tourigny JP; Forte E; Salinas RE; Dave SS; Luftig MA
    J Virol; 2012 Oct; 86(20):11096-106. PubMed ID: 22855490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Dual-Specificity Phosphatases by Epstein-Barr Virus LMP1 and Its Impact on Lymphoblastoid Cell Line Survival.
    Lin KM; Lin SJ; Lin JH; Lin PY; Teng PL; Wu HE; Yeh TH; Wang YP; Chen MR; Tsai CH
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.